Other terms
Extensively Drug Resistant Tuberculosis,Tuberculosis, Extensively Drug-Resistant,Drug-Resistant Tuberculoses, Extensively,Drug-Resistant Tuberculosis, Extensively,Extensively Drug-Resistant Tuberculoses,Tuberculoses, Extensively Drug-Resistant,Tuberculosis, Extensively Drug Resistant,XDR-TB,Extremely Drug-Resistant Tuberculosis,Drug-Resistant Tuberculoses, Extremely,Drug-Resistant Tuberculosis, Extremely,Extremely Drug Resistant Tuberculosis,Extremely Drug-Resistant Tuberculoses,Tuberculoses, Extremely Drug-Resistant,Tuberculosis, Extremely Drug-Resistant,Tuberculosis, Extremely Drug Resistant
Description
Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.